Godinho-Silva Cristina, Marques Sofia, Fontinha Diana, Veiga-Fernandes Henrique, Stevenson Philip G, Simas J Pedro
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Sir Albert Sakzewski Virus Research Center and Queensland and Children's Medical Research Institute, University of Queensland, Brisbane, Queensland, Australia.
PLoS Pathog. 2014 Jun 26;10(6):e1004220. doi: 10.1371/journal.ppat.1004220. eCollection 2014 Jun.
Persistent infections are subject to constant surveillance by CD8+ cytotoxic T cells (CTL). Their control should therefore depend on MHC class I-restricted epitope presentation. Many epitopes are described for γ-herpesviruses and form a basis for prospective immunotherapies and vaccines. However the quantitative requirements of in vivo immune control for epitope presentation and recognition remain poorly defined. We used Murid Herpesvirus-4 (MuHV-4) to determine for a latently expressed viral epitope how MHC class-I binding and CTL functional avidity impact on host colonization. Tracking MuHV-4 recombinants that differed only in epitope presentation, we found little latitude for sub-optimal MHC class I binding before immune control failed. By contrast, control remained effective across a wide range of T cell functional avidities. Thus, we could define critical engagement thresholds for the in vivo immune control of virus-driven B cell proliferation.
持续性感染会受到CD8 + 细胞毒性T细胞(CTL)的持续监测。因此,对它们的控制应依赖于MHC I类限制性表位的呈递。γ - 疱疹病毒有许多表位被描述,这些表位构成了前瞻性免疫疗法和疫苗的基础。然而,体内免疫控制对表位呈递和识别的定量要求仍不清楚。我们使用鼠疱疹病毒4型(MuHV - 4)来确定对于一个潜伏表达的病毒表位,MHC I类结合和CTL功能亲和力如何影响宿主定植。追踪仅在表位呈递上有差异的MuHV - 4重组体,我们发现在免疫控制失败之前,次优的MHC I类结合几乎没有余地。相比之下,在广泛的T细胞功能亲和力范围内,控制仍然有效。因此,我们可以为病毒驱动的B细胞增殖的体内免疫控制定义关键的参与阈值。